β-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer’s Disease
- 14 August 2015
- journal article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 36 (1) , 121-130
Abstract
Elevated β-amyloid (Aβ) is a hallmark of Alzheimer’s disease (AD). Recent evidence has suggested that the receptor of advanced glycation end products (RAGE) is a key target for Aβ-induced perturbation in AD, and blockade of RAGE significantly alleviates synaptic injury. Our previous study has suggested that β-asarone could reduce neuronal apoptosis and improve memory deficits in β-amyloid precursor protein and presenilin-1 (APP/PS1) double transgenic AD-model mice. In the present study, we evaluated the effects of β-asarone on amyloidosis in APP/PS1 mice. We found that the survival of neurons of APP/PS1 mice was improved by β-asarone, meanwhile, β-asarone decreased Aβ deposition and down-regulated Aβ1–42 levels in cortex and hippocampus of APP/PS1 mice brain. Interestingly, the level of RAGE was also significantly down-regulated by β-asarone. Our findings suggest that β-asarone might be effective for the treatment of AD, and the decreasing effects of β-asarone on Aβ might associate with its down-regulation of RAGE.Keywords
Funding Information
- National Major Science and Technology for Special Program of Creative Drug of China (2009ZX09103-429)
- Doctoral Fund of Education Ministry of China (20114425110007, 20134425110003)
- Scientific and Technical innovation Project of Guangdong Provincial Education Department of China (2012KJCX0032)
- the Characteristic Key Discipline Construction Fund of Chinese Internal Medicine of Guangzhou University of Chinese Medicine (2013-2015)
This publication has 38 references indexed in Scilit:
- RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2009
- New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's DiseaseNeurotherapeutics, 2008
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic DysfunctionJournal of Neuroscience, 2008
- Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular AmyloidJournal of Neuroscience, 2007
- Inflammation occurs early during the Aβ deposition process in TgCRND8 miceNeurobiology of Aging, 2004
- Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 miceAnnals of Neurology, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- The biology of the receptor for advanced glycation end products and its ligandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984